As part of the effort to achieve universal health coverage (UHC) in Nigeria, the Cross River State Ministry of Health (CRSMOH) recently conducted an orientation for health workers on the need to encourage women adoption of National Self-care/Self-injection plan.
The training in Uyo, Cross River state was facilitated with technical support from the Federal Ministry of Health, the World Health Organization (WHO) and partners. The main objective was to strengthen access to self-care/self-injection innovation in Nigeria and to educate frontline health care workers on the self-care guidelines for sexual reproductive health. Emphasis was on the scale-up of Depot-medroxyprogesterone acetate (DMPA-SC) self-injection.
Nigeria, in November 2016, approved injectable contraceptives for self-injection by users hoping that it would improve access to family planning services, especially in hard to reach places. However, the uptake of family planning services in Nigeria is still low, as analysis from the Nigeria Demographic and Health Survey shows that 19% of married women have an unmet need for family planning: 12% want to delay childbearing, while 7% want to stop childbearing.
Speaking to participants, Dr David E. Ushie the Special Adviser to the Governor on Health said that, while the training addressed the needs of women, Cross River State would strive to improve the levels of awareness and utilization of available interventions on reproductive health.
“The state is committed to creating an enabling environment in terms of the need for proper regulation and the orientation of our healthcare providers and the end-users to promote the guidelines on Self-Care. The concept and implementation of DMPA-SC would provide more family planning options for women in the reproductive age group and their partners in the public and private sectors across the 18 LGAs in the state”, he said.
A confident Mrs Chisom Emeka of WHO Nigeria, who was also at the training noted that, “This orientation will improve access and uptake of DMPA-SC- a self-injection contraceptive and improve the lives of many women who want to avoid pregnancy in Cross River state. It would also reduce infant and maternal mortality rates in the country”, she added.
Following the training, Mrs Eko Idam Edodi, a 34 year old health care worker at Primary Healthcare Centre in Biase local government area (LGA) stressed that she is now equipped with information on self-injection which she will use to mobilize other women in her locality to embrace the highly beneficial practice.
“With this knowledge about DMPA-SC self-injection, I will support women to make informed and positive decisions about their reproductive health. Also, it will give women of childbearing age the opportunity to make reproductive health choices for themselves.
The use of self-injection is cost-effective, promote privacy, saves time, reduce unintended pregnancies/abortions. It will also allow women to space childbirth and give their children the maximum attention and care they need”, she concluded.
Self-injected contraception is an innovative practice in family planning that is transforming contraceptive access and use. The new self-injectable contraceptive - DMPA-SC, allows women to inject themselves at the comfort of their homes and provides three months of protection. It would make contraceptive use affordable, accessible, and preserve the confidentiality of those using it. These would reduce morbidity in women and children as well as promote timely self-intervention.
Distributed by APO Group on behalf of World Health Organization (WHO) - Nigeria.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
